For example, tau mutations in familial FTDP-17 promote tau aggregation (3), induction of tau aggregates leads to toxicity in cells (4), and targeted reduction of tau and inhibition of tau aggregation reverses cognitive impairments in tauopathy mouse models (5, –7). Here, MAPT is linked to tauopathy.